Dimethicone / triamcinolone topical Pregnancy and Breastfeeding Warnings

Brand names: Dermawerx SDS Pak, Ellzia Pak, TriHeal-80, TriaDime, TriaDime-80, Yaliira Pak

Medically reviewed by Drugs.com. Last updated on Jun 24, 2022.

Dimethicone / triamcinolone topical Pregnancy Warnings

This drug should not be used during pregnancy unless the benefit outweighs the risk to the fetus.

US FDA pregnancy category: C

Comments:
-Systemically administered corticosteroids are generally teratogenic in laboratory animals at relatively low doses.
-The more potent corticosteroids showed teratogenicity in laboratory animal after topical application.
-This class of drugs should not be used extensively, in large amounts, or for prolonged periods during pregnancy.

Animal studies of this product are not available. Animal studies of systemic corticosteroids showed teratogenicity at relatively low doses and the more potent corticosteroids showed teratogenicity after topical application. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Dimethicone / triamcinolone topical Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments:
-It is unknown if topically applied corticosteroids have sufficient systemic absorption to produce detectable quantities in breast milk.
-Systemically administered corticosteroids are secreted in breast milk in quantities unlikely to adversely affect the infant

See references

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer